Cancer Treatment in Islamic Traditional Medicine

Arkus ◽  
2021 ◽  
Vol 7 (2) ◽  
pp. 155-159
Author(s):  
Rachmat Hidayat
Keyword(s):  
Cancer Treatment ◽  
Traditional Medicine ◽  
Treatment Options ◽  
Cancer Control ◽  
Alternative Methods ◽  
Literature Study ◽  
Islamic Medicine ◽  
Routes Of Administration ◽  
Treatment Services ◽  
And Control

Although significant progress has been made in cancer treatment in recent decades, the effectiveness of modern therapeutic approaches is often limited by their toxic effects on other organs. In addition, many people in the world have limited or unequal access to cancer treatment services. Therefore, utilizing information from traditional medicine systems to identify alternative methods to prevent and control cancer. The use of traditional medicine can lead to the discovery of new bioactive compounds and drugs that are available, safe and affordable. In Islamic medicine, cancer is known as a disease with many treatment options. Traditional Islamic medicine suggests several strategies for cancer control and treatment. Surgical manipulation, venesection, dietary adjustment, and use of natural medicines including solid, semisolid, and liquid dosage forms by oral and external routes of administration are among these methods. This literature study will presents cancer from the perspective of traditional Islamic medicine, its aetiology and management.

The optimal provision of cancer treatment services

2013 ◽  
Author(s):  
Michael Barton ◽  
Geoff Delaney
Keyword(s):  
North America ◽  
Early Detection ◽  
Cancer Treatment ◽  
Cancer Control ◽  
Treatment Modalities ◽  
Evidence Based ◽  
Treatment Services ◽  
Cancer Services ◽  
Different Populations

Chapter 9 describes an evidence-based approach to estimating the demand for cancer services and its application to different treatment modalities and different populations. The work was done mainly for Australia, but has been adapted and used in Europe and North America. Cancer services include all cancer control interventions such as screening, early detection, diagnosis, treatment, palliation, and rehabilitation. It also describes in detail the estimation of demand for radiotherapy and give examples of how this approach has been adapted to other modalities and other populations.

scholarly journals Emerging digital technologies in cancer treatment, prevention, and control

2021 ◽  
Vol 11 (11) ◽  
pp. 2009-2017 ◽  
Author(s):  
Bradford W Hesse ◽  
Dominika Kwasnicka ◽  
David K Ahern
Keyword(s):  
Behavioral Medicine ◽  
Cancer Treatment ◽  
Prevention And Control ◽  
Digital Health ◽  
Cancer Control ◽  
Digital Technologies ◽  
Health Technologies ◽  
The Usa ◽  
Anniversary Issue ◽  
And Control

Abstract The very first issue of the journal of Translational Behavioral Medicine (TBM) was dedicated, in part, to the theme of Health Information Technology as a platform for evidence implementation. The topic was timely: legislation in the USA was passed with the intent of stimulating the adoption of electronic health records; mobile smartphones, tablets, and other devices were gaining traction in the consumer market, while members within the Society of Behavioral Medicine were gaining scientific understanding on how to use these tools to effect healthy behavior change. For the anniversary issue of TBM, we evaluated the progress and problems associated with deploying digital health technologies to support cancer treatment, prevention, and control over the last decade. We conducted a narrative review of published literature to identify the role that emerging digital technologies may take in achieving national and international objectives in the decade to come. We tracked our evaluation of the literature across three phases in the cancer control continuum: (a) prevention, (b) early detection/screening, and (c) treatment/survivorship. From our targeted review and analyses, we noted that significant progress had been made in the adoption of digital health technologies in the cancer space over the past decade but that significant work remains to be done to integrate these technologies effectively into the cancer control systems needed to improve outcomes equitably across populations. The challenge for the next 10 years is inherently translational.

scholarly journals Joint Action on cancer iPAAC - building on experience and streamlining recommendations for the future

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
M Jelenc ◽  
T Albreht
Keyword(s):  
Cancer Care ◽  
National Level ◽  
Cancer Control ◽  
Professional Community ◽  
The Other ◽  
Consensus Building ◽  
Good Practices ◽  
Policy Initiatives ◽  
European Code ◽  
And Control

Abstract Background Policy initiatives, proposals and projects often end up proposing solutions and/or measures that are eventually either not or only partially implemented or they are lacking a system, which would consistently evaluate their implementation and/or impact. Good solutions are often not visible enough to the broader professional community and it is important to identify certain outstanding challenges in cancer control and policy. Driven by the need to better use the outputs from projects on cancer policy, European Commission was trying to address two challenges - one was in solving the problems with the implementation and use of the solutions that have already been proposed and the other one in identifying the outstanding challenges in cancer policy. Results We have decided to follow the structure to develop a series of recommendations and examples of good practices at the national level by selected areas. These would be streamlined into a roadmap to support policymakers at the national and EU level in formulating their cancer policies. Three pairs of targeted recommendations have been identified: Cancer prevention, including health promotion, implementation of the European Code Against Cancer and the reshaping and extension of cancer registriesGenomics and immunotherapy in cancerChallenges in cancer care and governance of cancer control Conclusions Multinational collaboration can bring about important consensual solutions, which build on the existing good practices in the countries. This can be combined well with the existing work on specific areas, carried out both internationally and nationally. Consensus building on jointly defined challenges represents a task that appears to be resolved rather pragmatically. Key message It is important that advance in cancer care and control are quickly analysed and that policymakers receive up-to-date recommendations to improve their policies on cancer control.

TO EVALUATE THE EFFECT OF PROPHYLACTIC USE OF TRENEXAMIC ACID ON BLEEDING DURING ELECTIVE LSCS. A STUDY CONDUCTED IN TERTIARY CARE HOSPITAL OF CENTRAL INDIA.

2021 ◽  
pp. 223-225
Author(s):  
Dhara Singh ◽  
Sujata bhargava
Keyword(s):  
Blood Loss ◽  
Tranexamic Acid ◽  
Tertiary Care ◽  
Alternative Methods ◽  
World Health ◽  
Study Cohort ◽  
Care Hospital ◽  
Total Blood ◽  
And Control ◽  
The Impact

Background: Recent guidelines of the World Health Organization (WHO) indicated administering tranexamic acid (TXA) in order to treat postpartum bleeding (PPH). Therefore, nding low-cost and lowrisk alternative methods to control obstetric bleeding is of great importance. The present study aimed to evaluate the prophylactic effect of TXA on bleeding during and after the LSCS. In addition, it was attempted to explore the impact of TXA as a safe and inexpensive method for decreasing bleeding during and after CS so that to decrease the hazard of blood transfusion or hysterectomy in these patients. Material and Methods: This prospective study conducted on 100 women in Department of Obstetrics &gynecolgy for one year period. They were divided in two groups: Cases: (n=50; women receiving prophylactic Tranexamic Acid) and Control: (n=50; women receiving saline). Estimated the amount of blood loss during surgery. The amount of blood loss during surgery were calculated Estimation of weight of dry towels and mops before autoclaving is noted. Results: Most common age group among Cases and Control was 26-30 years .%. Mean age among cases group (26.69±7.51 years) was signicantly lesser compared to control study cohort (29.75±7.72). Post operativehemoglobin level was signicantly higher among Case (11.26±12.03) as compared to Control (8.56±1.01). Comparing post operative complications revealedno signicant changes. Use of topical hemostatics was higher among the control (77%) as compared to Cases (57%). Conclusion: Prophylactic treatment with TXA in relation to elective LSCS reduces the overall total blood loss, and the risk of reoperations owing to postoperative hemorrhage as revealed by higher hemoglobin level among cases.

scholarly journals The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

2021 ◽  
Vol 12 ◽  
pp. 375-401
Author(s):  
Nikola Geskovski ◽  
Nadica Matevska-Geshkovska ◽  
Simona Dimchevska Sazdovska ◽  
Marija Glavas Dodov ◽  
Kristina Mladenovska ◽  
...  
Keyword(s):  
Cancer Treatment ◽  
Solid Tumors ◽  
Myeloid Leukemia ◽  
Treatment Options ◽  
Molecular Signatures ◽  
Design Strategies ◽  
Diagnostic Modality ◽  
Safety And Efficacy ◽  
Detection And Diagnosis ◽  
The Impact

Nanomedicine has emerged as a novel cancer treatment and diagnostic modality, whose design constantly evolves towards increasing the safety and efficacy of the chemotherapeutic and diagnostic protocols. Molecular diagnostics, which create a great amount of data related to the unique molecular signatures of each tumor subtype, have emerged as an important tool for detailed profiling of tumors. They provide an opportunity to develop targeting agents for early detection and diagnosis, and to select the most effective combinatorial treatment options. Alongside, the design of the nanoscale carriers needs to cope with novel trends of molecular screening. Also, multiple targeting ligands needed for robust and specific interactions with the targeted cell populations have to be introduced, which should result in substantial improvements in safety and efficacy of the cancer treatment. This article will focus on novel design strategies for nanoscale drug delivery systems, based on the unique molecular signatures of myeloid leukemia and EGFR/CD44-positive solid tumors, and the impact of novel discoveries in molecular tumor profiles on future chemotherapeutic protocols.

scholarly journals Minding the Gap: Addressing the Lack of Awareness and Supportive Services for Cancer Patients and Caregivers in Limited-Resource Settings

2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 106s-106s
Author(s):  
C. Taylor
Keyword(s):  
Cancer Patients ◽  
Positive Impact ◽  
Treatment Options ◽  
Cancer Control ◽  
Limited Resource ◽  
Hospital Staff ◽  
Final Report ◽  
Conference Calls ◽  
Compliance To Treatment ◽  
Knowledge Of Cancer

Background: In limited resource settings, physicians, particularly oncologists, are overburdened and there is an enormous health literacy gap between patients, caregivers and their doctors. Additionally, patients and caregivers are often required to travel great distances to unfamiliar cities to access cancer care. As a result, these patients and caregivers who require instruction and education about their illness are often overlooked and left uninformed, frightened and confused about their treatment and future. Aim: To fill gaps in education, navigation and awareness for cancer patients and caregivers during treatment. Provide practical information specific to their disease and treatment, encourage patient compliance with treatment and to equip them with the knowledge and resources that could have a positive impact on the patient's outcome as well as ease burden on the overtaxed hospital staff. Methods: Working in partnership with local and international cancer control experts, health ministries, clinicians, advocates and caregivers to build and introduce a program consisting of 2 components; patient/caregiver information/navigation support, at 5 sites in Colombia and Vietnam in 2018. The information component will comprise of a series of short videos/info-graphics providing culturally and resource appropriate information about cancer, its treatment, risk factors, treatment options, side effects and precautions including advice on hygiene, nutrition/diet. The navigation component engages hospital staff to map and provide local information and resources on affordable lodging, food and transportation services. Both components will be easily adaptable for each location, and accessible to varying levels of literacy via TV/video monitors/kiosks located in key areas of the hospital and via printed materials. If available, we will network to vetted local social media and Web based resources. Results: We will document the project through conference calls and site visits. We will convene stakeholders and beneficiaries to provide feedback on the implementation and effectiveness of the project. In the absence of a specific advocacy body to apply to for certification, we will use our advisory board, comprised of clinical experts in the field to provide feedback, guidance and critique in the development/evaluation of the materials. The feedback, along with analyses of the project outcomes, will be included in a final report, presented at appropriate conferences and published in relevant professional publications. Conclusion: Expected results: Increased patients' and caregivers' knowledge of cancer and cancer treatment Improved patient's and caregiver's levels of perceived support Reduced stress for patients and caregivers Increase compliance to treatment Reduced patient support burden for hospital staff

scholarly journals The Impact of Stigma and Discrimination on Adherence to Medication amongst People Living with HIV in Tiv Land, North Central Nigeria

2019 ◽  
pp. 1-9
Author(s):  
Godwin Aondohemba Timiun ◽  
Timothy J. Scrase
Keyword(s):  
People Living With Hiv ◽  
Structured Interviews ◽  
Hiv Patients ◽  
Stigma And Discrimination ◽  
Treatment Services ◽  
Adherence To Medication ◽  
Multi Stage ◽  
Living With Hiv ◽  
And Control ◽  
The Impact

In spite the identification of stigma as a factor impeding public utilisation of HIV counselling, testing, and treatment services in Nigeria, gaps still exist in knowledge on the impact of stigma, and discrimination on adherence to medication amongst people living with HIV (PLWH). This study adopted mixed methods to examine the impact of stigma and discrimination on adherence to medication amongst PLWH in Nigeria.  A sample of 1,621 respondents was collected using multi-stage and purposive sampling methods. Structured interviews using questionnaires and in-depth interviews (using a guide) were utilised for data collection. SPSS (version 21) was used for quantitative data analysis while the qualitative data was analysed thematically. There are 46.3% men and 53.7% women respondents. Generally, their income is low, 70.7% are earning less than N25, 000 (approximately $125 USD) per month. Some of the HIV patients are stigmatised. In reaction, they avoid public places, travel long distances away from their immediate community to collect drugs and to avoid been noticed around the centers. They sometimes miss taking drugs regularly as prescribed, suffer depression and die. Stigma and discrimination impede adherence to medication amongst PLHW in Nigeria. More efforts should be made to create awareness to reduce stigma and discrimination of HIV patients, while augmenting their income to meet up with the challenges of adherence to medication. The overall benefits would be enhanced mechanism of HIV prevention, treatment and control in the study area.

scholarly journals Attenuation of Circulating Trimethylamine N-Oxide Prevents the Progression of Cardiac and Renal Dysfunction in a Rat Model of Chronic Cardiorenal Syndrome

2021 ◽  
Vol 12 ◽  
Author(s):  
Deling Zou ◽  
Yanyu Li ◽  
Guangping Sun
Keyword(s):  
Gene Expression ◽  
Renal Dysfunction ◽  
Treatment Options ◽  
Elevated Serum ◽  
Kidney Injury ◽  
Cardiorenal Syndrome ◽  
Current Treatment ◽  
Sprague Dawley ◽  
Kidney Injury Molecule 1 ◽  
And Control

Chronic heart failure (HF) frequently causes progressive decline in kidney function, known as cardiorenal syndrome-2 (CRS2). Current treatment options for CRS2 remain unacceptably limited. Trimethylamine-N-oxide (TMAO), a metabolite of gut microbiota, has recently been implicated in the pathogenesis of both HF and chronic kidney disease. Here we examined whether circulating TMAO is elevated in CRS2 and if so, whether attenuation of circulating TMAO would ameliorate the progression of CRS2. Sprague-Dawley rats underwent surgery for myocardial infarction (MI) or sham (week 0) followed by subtotal (5/6) nephrectomy (STNx) or sham at week 4 to induce CRS2 or control. At week 6, MI + STNx rats and control rats received vehicle or 1.0% 3,3-Dimethyl-1-butanol (DMB, a TMAO inhibitor) treatment for 8 weeks. Compared with control rats, MI + STNx rats exhibited elevated serum TMAO at week 6, which was increased further at week 14 but was attenuated by DMB treatment. MI + STNx rats showed cardiac dysfunction as assessed by echocardiography and renal dysfunction as evidenced by increased serum creatinine and urinary kidney injury molecule-1 and decreased creatinine clearance at week 6. The cardiac and renal dysfunction in MI + STNx rats was exacerbated at week 14 but was prevented by DMB treatment. Molecular and histological studies revealed myocyte hypertrophy and increases in interstitial myocardial fibrosis and gene expression of pro-hypertrophic and pro-fibrotic markers in both heart and kidney at week 14, which were accompanied by elevated gene expression of proinflammatory cytokines. The changes in molecular and histological parameters observed in MI + STNx rats were significantly reduced by DMB treatment. These findings suggest that rats with CRS2 have elevated circulating TMAO, which is associated with the exacerbation of cardiac and renal dysfunction. Attenuation of circulating TMAO can ameliorate cardiac and renal injury and prevents the progression of CRS2.

Sign in / Sign up

Export Citation Format

Share Document